1. Tumor infiltrating lymphocyte volume is a better predictor of neoadjuvant therapy response and overall survival in triple negative invasive breast Cancer
   Lin Zhang et al, 2018, Human Pathology CrossRef
2. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo
   Hassan Moghtaderi et al, 2017, Biomedicine & Pharmacotherapy CrossRef
3. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
   Silvana Anna Maria Urru et al, 2018, BMC Cancer CrossRef
4. Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis.
   Qiang Wu et al, 2019, Front Oncol CrossRef
5. Prognostic value of the Ki-67 proliferation index in patients with triple negative breast carcinoma. Preliminary report
   Ángel Fernández et al, 2020, Invest Clin CrossRef
6. Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines
   Nath�lia Sonehara et al, 2018, Oncol Lett CrossRef
7. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
   Abeer H. Abdelhafez et al, 2020, Breast Cancer Res Treat CrossRef
8. Assessment of PD‐L1 expression and tumor‐infiltrating lymphocytes (TILs) across molecular subtypes of triple‐negative breast cancer
   Ridhi Sood et al, 2020, Breast J CrossRef
9. Molecular Subtyping of Triple Negative Breast Cancer by Surrogate Immunohistochemistry Markers
   Sandeep Kumar et al, 2021 CrossRef
10. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
    Mahdi Abdoli Shadbad et al, 2021, Front. Oncol. CrossRef
11. A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes
    Tae-Kyung Yoo et al, 2022, Breast Cancer Res Treat CrossRef
12. Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes
    Nah Ihm Kim et al, 2022 CrossRef
13. Deep learning-based automatic segmentation for size and volumetric measurement of breast cancer on magnetic resonance imaging
    Wenyi Yue et al, 2022, Front. Oncol. CrossRef
14. Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
    Asad Mustafa Karim et al, 2023, Biochemical Pharmacology CrossRef
15. Triple-Negative Breast Carcinoma Subtyping by Immunohistochemistry – Our Experience
    Pangarkar Meena et al, 2024 CrossRef